The current development status of the in vitro diagnostic raw material market and how to survive in the cracks
Release time:
2025-04-20
The in vitro diagnostics (IVD) industry, as a key component of the modern medical system, plays an irreplaceable role in early screening, accurate diagnosis, and preventive monitoring of diseases. The IVD raw material market, as the foundation supporting the entire IVD industry, has shown a thriving trend in recent years. But behind the seemingly prosperous situation, there are also many challenges hidden, and enterprises need to find a path for survival and development under heavy pressure.
What factors are related to market growth
1. Increased risk of illness
With the aggravation of population aging and the change of people's lifestyle, the incidence rate of chronic diseases and infectious diseases continues to rise. Cardiovascular disease, diabetes, cancer and other diseases, as well as HIV, hepatitis B, hepatitis C and other infectious diseases are widely prevalent, which makes the demand for IVD products grow rapidly. Every year, there are approximately 3 to 5 million severe cases and 250000 to 500000 deaths caused by influenza, highlighting the importance of rapid and accurate diagnosis and driving a large demand for related raw materials in the market.
2. The Rise of Personalized Medicine
Personalized medicine emphasizes developing plans based on individual patient characteristics, with IVD devices playing a central role in it. From common pregnancy tests and blood glucose monitoring to complex cancer screening, IVD devices can provide personalized diagnostic information for patients. With the continuous advancement of technology, more and more IVD manufacturers are engaging in digital strategies and developing devices that are more convenient for patients to use. This trend further promotes the development of the IVD raw material market, and the research and production of personalized medical equipment require high-quality and highly specific raw material support.
3. The driving force of technological progress
Technological innovation in the IVD industry is constantly emerging. The development of real-time quantitative PCR (qPCR) technology has expanded the application scope of molecular diagnostics in the medical field. The advancement of technologies such as immunohistochemistry and clinical chemistry has also brought new growth opportunities to the IVD raw material market. Some advanced POC (On site Rapid Testing) equipment can achieve fast and accurate diagnosis, meeting the urgent demand for real-time testing in clinical practice, which has prompted manufacturers to increase investment in research and production of related raw materials.

IVD market segmentation
1. The IVD raw material market can be divided into antibodies and antigens, enzymes, proteins, biological buffering agents, and other products according to product types. In 2021, antibodies and antigens held a high market share of 36.24%. Enzyme based raw materials are widely used in fields such as immunoassays and molecular diagnostics, as enzyme reagents for detecting biomarkers such as creatine kinase isoenzyme (CK-MB) in myocardial infarction. Different types of raw materials play their respective roles in IVD testing, meeting diverse testing needs.
2. The main end users of IVD raw materials include pharmaceutical and biotechnology companies, diagnostic laboratories, and other users. In 2021, pharmaceutical and biotechnology companies held 62.19% of the market share, and with the widespread application of antigen antibody testing and POC diagnostic technology, their demand for IVD raw materials continues to increase. As the main application site for IVD products, diagnostic laboratories have a strong demand for raw materials. Other users such as hospitals, research institutions, and clinical research centers are also driving the development of the IVD raw material market. The demand characteristics and application scenarios of raw materials vary among different end users, which requires raw material suppliers to have diversified product supply capabilities and customized service capabilities.
3. From a geographical distribution perspective, Europe held a high market share of 35.00% in the domestic and international IVD raw material market in 2021. Its mature medical equipment industry and comprehensive IVD instrument and product system have laid the foundation for its market position. The Asia Pacific region is expected to become the fastest-growing region, with a compound annual growth rate of 45.08%. This growth is attributed to the continuous improvement of infrastructure in the region, the increase in the patient population, and the rapid development of personalized medicine.
Strategies for survival in the cracks
(1) Strengthen research and development innovation
Enterprises should continue to increase research and development investment, improve product quality and performance, in order to meet increasingly strict regulatory requirements and customer needs. To address the issue of inter batch differences, measures such as optimizing production processes and strengthening raw material quality control are taken to ensure product stability and consistency. Continuously developing new raw materials to meet the development needs of personalized medicine and POC diagnostic technology, developing high-performance and miniaturized raw materials suitable for POC devices, and enhancing product competitiveness.
(2) Expand into emerging markets
Pay attention to the growth potential of emerging markets, especially rapidly growing regions such as the Asia Pacific region. Develop products and solutions suitable for local market demand based on the characteristics of low - and middle-income groups, such as providing affordable and easy-to-use IVD raw materials, assisting in the establishment of laboratory infrastructure and quality management systems, improving product penetration, and expanding business scope.
As a research and development supplier of IVD reagent raw materials, Hubei Xindesheng can provide a full range of products, including biological buffering agents, colorimetric reagents, luminescent reagents, enzyme preparations, antigen antibodies, etc., suitable for various diagnostic experiments. If you need it, please feel free to contact us!
Contact details
Contact number
Address: C8, Guanggu United Science and Technology City, Ezhou City, Hubei Province
Fax:0711-3704 589
Follow us